1262751-08-5
1262751-08-5 结构式
物理化学性质
应用领域
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-P1489A | OVA Peptide (257-264) TFA OVA Peptide(257-264) TFA | 1262751-08-5 | 1mg | 900元 |
| 2025/12/22 | HY-P1489A | OVA Peptide (257-264) TFA OVA Peptide(257-264) TFA | 1262751-08-5 | 5mg | 1360元 |
| 2025/12/22 | HY-P1489A | OVA Peptide (257-264) TFA OVA Peptide(257-264) TFA | 1262751-08-5 | 10mg | 1950元 |
常见问题列表
TAP1-I- and C57BL/6 macrophages may process Crl-OVA and full-length OVA in different cellular compartments and that the protein context of the OVA Peptide(257-264) epitope influences the extent of TAP-independent processing for MHC class I presentation. OVA Peptide(257-264) epitope is presented with a differential dependence on the TAP transporter depending on the protein context of the OVA epitope: OVA Peptide(257-264) contained within the MBPCrl-OVA or Crl-OVA bacterial fusion proteins is presented with little dependence on the TAP transporter, while OVA Peptide(257-264) contained within full-length ovalbumin is largely dependent on the TAP transporter, regardless of whether recombinant OVA is expressed in bacteria or the native protein is coupled to polystyrene beads.